PubMed
Gonadotropin-releasing hormone agonists and antagonists in assisted reproduction
Al-Inany HG, Youssef MA, Aboulghar M, et al. Cochrane Database Syst Rev. 2016
Compare
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
Last reviewed . By the PeptIQ team.
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 48% · Mixed 44% · Unfavorable overall 8%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 100–200 mcg · Most common: 100–200 mcg
Reports span 10–1000 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 58% said they felt similar to their last entry, 40% more positive, and 18% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 14 days · Based on 164 repeat reporters
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 67% · Mixed 24% · Unfavorable overall 9%
Benefits users selected when logging a favorable or mixed check-in.
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Median bucket: 0.2–0.4 mg · Most common: 0.2–0.4 mg
Reports span 0.01–3 mg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 62% said they felt similar to their last entry, 41% more positive, and 17% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 15 days · Based on 491 repeat reporters
Published sources linked on the Gonadorelin and KLOW Blend wiki pages.
PubMed
Al-Inany HG, Youssef MA, Aboulghar M, et al. Cochrane Database Syst Rev. 2016
PubMed
Collado-Sole A, Borjini N, Zhai J, et al. Science (New York, N.Y.). 2026
PubMed
Moore AM. eLife. 2024
PubMed
Sikiric P, Seiwerth S, Rucman R, et al. Curr Pharm Des. 2018
PubMed
Goldstein AL, Kleinman HK. Expert Opin Biol Ther. 2010
Review Article
Pickart L, Margolina A. Cosmetics. 2018
PubMed
Luger TA, Brzoska T. Ann N Y Acad Sci. 2004